Feasibility and Acceptability of a Yogic Breathing/Mindfulness Meditation e-Intervention on Symptoms and COVID-19–Associated Anxiety in Patients Receiving Dialysis
Jordan A Carver, Katharine L. Cheung
Journal of Palliative Medicine April 5, 2021 DOI: 10.1089/jpm.2021.0161 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Anxiety Meditation |
| Key points | The text states that end-stage kidney disease has a one-year mortality rate of 20%–25%, that incidence is expected to rise 11%–18% by 2030 relative to 2015, and that patients on dialysis experience a high burden of symptoms that are often unaddressed during treatment. |
Abstract
Kidney failure, or end-stage kidney disease (ESKD), is a life-altering condition, with a one-year mortality rate of 20%–25%, 1 and the incidence is expected to rise 11%–18% by 2030, compared with 2015 levels. 2 Patients with kidney failure experience a high burden of symptoms that are often unaddressed during their dialysis treatments. The COVID-19 pandemic
Citations in the library
Cited by 3
- Experiences of People with Kidney Disease Following the Implementation of the Compassionate Mindful Resilience Programme: Qualitative Findings from the COSMIC Study. Healthcare November 8, 2023
- Examining the acceptability and feasibility of the Compassionate Mindful Resilience (CMR) programme in adults living with chronic kidney disease: the COSMIC study findings. BMC nephrology January 31, 2024
- The Role of Mindfulness in Hemodialysis Patients: A Scoping Review Mindfulness September 9, 2026